Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Completed
×
Diabetes Mellitus, Insulin-Dependent, 12
×
Clear all
Filters
3
NCT03302234
2023-09-26
KEYNOTE-598
Merck Sharp & Dohme LLC
Phase 3
Completed
568 enrolled
20 charts
NCT03084471
2022-12-22
STRONG
AstraZeneca
Phase 3
Completed
867 enrolled
10 charts